Taiwan FDA registration 390456fa874aa84c3d443501649bf6ad

BeneCheck Supreme Blood Glucose Monitoring System

TW: 百捷優善血糖檢驗系統

Taiwan·Risk Class 2·MD·Qinli Biotechnology Co., Ltd. new tree factory·Registered Dec 02, 2019 – Dec 02, 2024Expired

Registration details

Analysis ID: 390456fa874aa84c3d443501649bf6ad
License Form: Ministry of Health Medical Device Manufacturing No. 006483

Company information

Manufacturer: Qinli Biotechnology Co., Ltd. new tree factory
Manufacturer Country: Taiwan, Province of China
Authorized Representative: GENERAL LIFE BIOTECHNOLOGY CO., LTD.

Product details

Intended Use: This product can quantitatively detect the blood glucose concentration of fingertips, palms or forearm microvascular whole blood and venous blood. This system is suitable for home self-testing and professional detection of the patient's microvascular whole blood glucose concentration, and also suitable for professionals to detect the patient's venous blood glucose concentration.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A1345 Glucose Test System
Import Information: Produced in Taiwan, China

Dates and status

Registration Date: Dec 02, 2019
Expiry Date: Dec 02, 2024

About this record

Access comprehensive regulatory information for BeneCheck Supreme Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 390456fa874aa84c3d443501649bf6ad and manufactured by Qinli Biotechnology Co., Ltd. new tree factory. The authorized representative in Taiwan is GENERAL LIFE BIOTECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.